New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial.

Wienbergen H, Fach A, Erdmann J, Katalinic A, Eisemann N, Krawitz P, Maj C, Borisov O, Munz M, Noethen M, Meyer-Saraei R, Osteresch R, Schmucker J, Linke A, Eitel I, Hambrecht R, Langer H.

Clin Res Cardiol. 2020 Jul 30. doi: 10.1007/s00392-020-01695-w.

https://pubmed.ncbi.nlm.nih.gov/32734504/

Scroll to Top